CERo Therapeutics Holdings, Inc. Warrants
Symbol: CEROW (NASDAQ)
0.01
▲ (0.71%) 0.000
Company Description:
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
Key Stats
- Today's Open: $0.0141
- Today's High: $0.0142
- Today's Low: $0.0141
- Today's Volume: 12.09K
- Yesterday Close: $0.0141
- Yesterday High: $0.0153
- Yesterday Low: $0.014
- Yesterday Volume: 8.20K
- Last Min Volume: 3.51K
- Last Min High: $0.0142
- Last Min Low: $0.0142
- Last Min VWAP: $0.0142
Company Profile
- Name: CERo Therapeutics Holdings, Inc. Warrants
- Website: https://www.cero.bio
- Listed Date: 2024-02-15
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001870404
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $
- Round Lot: 100
- Outstanding Shares:
- Asset Type: WARRANT
RECENT FILINGS FOR CEROW
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | 8-K | View |
| 2025-09-05 | 424B3 | View |
| 2025-09-05 | 424B3 | View |
| 2025-09-05 | 8-K | View |
| 2025-09-04 | 424B3 | View |
| 2025-09-04 | 424B3 | View |
| 2025-09-04 | 8-K | View |
| 2025-08-22 | 424B3 | View |
| 2025-08-22 | 424B3 | View |
| 2025-08-22 | 10-Q | View |
| 2025-08-15 | EFFECT | View |
| 2025-08-15 | NT 10-Q | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | CORRESP | View |
| 2025-08-14 | UPLOAD | View |
| 2025-08-11 | S-3 | View |
| 2025-07-29 | EFFECT | View |
| 2025-07-28 | S-8 | View |
| 2025-07-28 | CORRESP | View |
| 2025-07-25 | 424B3 | View |